Study Summary
This trial tests a new radiation therapy for prostate cancer, aiming to reduce side effects and be safe & feasible.
- Prostate Cancer
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 18 Secondary · Reporting Duration: At screening, end of radiotherapy (week 5), 3 months after start of radiotherapy, and every 3 months until month 24
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Adaptive stereotactic body radiotherapy (SBRT)
1 of 1
Experimental Treatment
25 Total Participants · 1 Treatment Group
Primary Treatment: Adaptive stereotactic body radiotherapy (SBRT) · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · Male Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is recruitment still ongoing for this trial?
"Clinicaltrials.gov reports that this trial has no longer been actively seeking participants since its last update on November 16th 2022. First posted 31st December of the same year, it is now one among 1321 other studies still recruiting patients at present." - Anonymous Online Contributor